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a b s t r a c t
The simple and low cost -cyclodextrin (-CD)–phenolphthalein (PHP) inclusion complex was used for
both the study of physical–chemical parameters and validation of analytical procedures for deoxycholic
acid (DCA) and ursodeoxycholic acid (UDCA) determinations in different formulations. The usefulness of
this inclusion complex is proposed either in the form of kit reagent and as an original optical sensor for
DCA and UDCA. The results showed that temperature had a negative effect on the equilibrium constant
resulting in high negative values of enthalpy and positive values of entropy. The half-life values foreywords:
eoxycholic acid
rsodeoxycholic acid
-Cyclodextrin
nclusion complex
henolphthalein
DCA and UDCA measurements were 68.71 and 294.71 days, respectively. The method was validated
showing limits of detection and quantiﬁcation of 4.92×10−5 mol L−1 and 1.64×10−4 mol L−1 for DCA,
1.14×10−5 mol L−1 and 3.79×10−5 mol L−1 for UDCA, respectively. The developed optical sensor also
showed response linearity, ease of implementation and potential application in fast screening tasks even
out of the laboratory.
© 2010 Elsevier Ireland Ltd. Open access under the Elsevier OA license.
ptical sensor
. Introduction
Besidesplayingan importantphysiological role inbiological sys-
ems some bile acids such as the deoxycholic acid (DCA), are also
mployed to enhance oral availability of biodegradable nanoparti-
les (Samstein et al., 2008), as choleretic agent in liver dysfunctions
Rodriguez et al., 2000), as N-(2-dimethylamino)ethyl derivatives
n malaria treatment (Terzic et al., 2007) and in several cosmetic
reparations (Valenta et al., 1999). Injection lipolysis for sub-
utaneous application primarily aiming cosmetic proposes were
nitially used in Brazil. They were based on a mixture of phos-
hatidylcholine and DCA as major active components (Duncan
t al., 2009; Rotunda et al., 2004), being lately replaced by formu-
ations containing only DCA (Rotunda and Kolodney, 2006; Yagima
do et al., 2007). However, due to the associated health risks
oth of them have been forbidden by national sanitary authorities
ike ANVISA (the Brazilian National Health Surveillance Agency)
∗ Corresponding author at: Lab. de Imunopatologia Keizo Asami (LIKA), Universi-
ade Federal de Pernambuco (UFPE), Av. Prof. Moraes Rego, s/n 50780-901 Recife,
ernambuco, Brazil. Tel.: ++55 81 2126 8484; fax: +55 81 2126 8485.
E-mail address: pabyton@yahoo.com.br (P.G. Cadena).
009-3084 © 2010 Elsevier Ireland Ltd. 
oi:10.1016/j.chemphyslip.2010.11.004
Open access under the Elsevier OA license.and FDA in US. Another important bile acid, the ursodeoxycholic
acid (UDCA) is also used in the treatment of primary biliary cir-
rhosis, primary cholangitic sclerosis (Lindor, 1997), cholelithiasis
(Petroni et al., 2001), to prevent the relapse of acute pancreatitis
caused by microlithiasis (Okoro et al., 2008) and to reduce ala-
nine aminotransferase levels in hepatitis C (Ikegami andMatsuzaki,
2008).
Due to stated applications of both bile acids, a variety of meth-
ods are routinely used to measure their content in pharmaceutical
formulations, such as: electrochemical (voltammetric), ﬂuorimet-
ric or spectrophotometric (Arias De Fuentes et al., 2000), HPLC
(Scalia et al., 1989) and micellar electrokinetic chromatographic
(Rodriguezet al., 2000).Nevertheless, eachof onehas its owndisad-
vantage (Arias De Fuentes et al., 2000; Lin et al., 2003) which added
to complexity of the samples treatment turn difﬁcult the “in loco”
control by national sanitary authorities thus usually addressing the
formulation or cosmetic sample into the laboratory for further pro-
cessing and analysis. The research about validated simple and low
cost methods for measurement of bile acids in commercial formu-
lations can be also useful for screening tasks during technological
development replacing expensive technologies more difﬁcult to
access in developing countries. In this way, inclusion complexes
formed between cyclodextrins and indicators provide the basis
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or simpliﬁed methods of measurement of hydrophobic molecules
uch as is the case of bile acids (Cadena et al., 2009).
The important property of cyclodextrins (CDs) – cyclic oligosac-
harides with six (-), seven (-) or eight (-) glucose residues
inked by -(1–4) glycosidic bonds (Yanez et al., 2004) – and their
umerous derivatives is the ability to form inclusion complexes
ith inorganic and organic guests (Brewster and Loftsson, 2007).
oncomitantly, inclusion in cyclodextrins exerts a profound effect
n the physicochemical properties of guest molecules such as sol-
bility, chemical stability, absorption and bioavailability (Zhang
t al., 2009). Guests reactionwith CDs by competitive complexation
ith indicators has been used to assess the respective equilibrium
onstants (Kc) and other related thermodynamic parameters due to
he fails in the direct determination of the complex. For example,
henolphthalein (PHP) is a typical acid/base indicator that forms a
olourless1:1 inclusioncomplexwith-CDandby thisused in indi-
ect determinations of other colourless compounds by competitive
omplexation reaction (Afkhami et al., 2006; Glazyrin et al., 2004).
Herein, the temperature dependence of the equilibrium con-
tants of the PHP–, DCA– and UDCA–-cyclodextrin were used
o obtain thermodynamic parameters, i.e. the free energy change
G), the enthalpy change (H) and the entropy change
S). The usefulness of the obtained data is evidenced in the
ubsequent validation of analytical procedures based on the -
yclodextrin–phenolphthalein (-CD–PHP) inclusion complex as
it reagent or optical sensor both providing rapid, inexpensive and
imple alternative method for “in loco” measurements and fast
creening.
. Experimental
.1. Materials
Analytical grade chemicals without any further puriﬁcation
reatment and double deionised water were used thoroughly.
-cyclodextrin was obtained from Fluka (Steinheim, Germany).
henolphthalein, deoxycholic acid (sodium salt) and ursodeoxy-
holic acid were obtained from Sigma (St. Louis, MO, USA).
bsorption spectra were collected from a Pharmacia Ultrospec
000pro UV/Vis spectrophotometer using 1-cm path length quartz
ells. Statistical evaluations were carried out by Statistica software
StatSoft Inc., Tulsa, OK, USA) and the images were analysed by trial
ersion of Adobe Photoshop CS2 software (Adobe Systems, USA).
.2. Methods
.2.1. Preparation of analytical reagent
The co-precipitation technique (Del Valle, 2004) enabled to
repare the inclusion complexes in batch conditions using the
ollowing solutions: 1mL of phenolphthalein solution, 1mL of car-
onate buffer solution (pH 10.5; 150mmol L−1) (Afkhami et al.,
006) and1mLof-CD solution. Forhaving ahomogeneous system
he mixture was vigorously mixed after each solution addition (the
rder did not interferes in the result), then readily transferred into
dark ﬂask and kept at room temperature (25 ◦C). Humidity and
emperature effects were considered neglected because all exper-
ments and kit storage were performed in the same acclimatized
oom.
.2.2. Development of the method (kit reagent)
The competitive inclusion complexes above obtained were just
omogenized with either 1mL of water (control) or 1mL of bile
cid solution (sample). The positive control to study the absorbance
f the phenolphthalein was made using 1mL of PHP solution, 1mL
arbonate buffer (pH 10.5; 150mmol L−1) and 2mL ofwater, whichics of Lipids 164 (2011) 99–105
was stronglymixed after each solution addition. The blank solution
was composed of 1mL the same buffer plus 3mL of water.
Absorption spectra were obtained at pH 10.5, containing
1.55×10−4 mol L−1 phenolphthalein (PHP) and different amounts
of -cyclodextrin (-CD), 3.88×10−5 up to 6.20×10−4 mol L−1, at
25 ◦C. Spectra for DCA analysis were carried out using 4.38×10−5
up to 7.0×10−4 mol L−1 DCA solutions and -CD–PHP complex
in the ﬁxed proportion of 6.2×10−4:1.55×10−4 mol L−1. In turn,
for UDCA analysis 1.19×10−5 up to 1.9×10−4 mol L−1 solutions
of this bile acid were assayed with the -CD–PHP complex
(3.1×10−4:7.75×10−5 mol −1).
Temperature effectwas assessed in the range from10up to55 ◦C
for the 8.75×10−5 up to 1.40×10−3 mol L−1 DCA and 2.38×10−5
up to 1.9×10−4 mol L−1 UDCA concentrations, while keeping pH
constant at the value of 10.5.
The effect of the ionic strength on inclusion complex forma-
tion with DCA or UDCA and -CD was examined in the range from
0.11 up to 0.40 using -CD–PHP – 6.2×10−4:1.55×10−4 mol L−1
for DCA and 3.1×10−4:7.75×10−5 mol L−1 for UDCA, according to
Wang et al. (2007).
Storage stability of the kit reagent developed was evaluated
by maintaining two solutions of this complex at 25 ◦C during 60
days in dark ﬂasks. At deﬁned time intervals, samples were with-
drawn from each of one for testing with solutions containing
7.0×10−4 mol L−1 of DCA and 1.9×10−4 mol L−1 of UDCA, respec-
tively.
2.2.3. Validation of the method (kit reagent)
The methodology used to validate the determination of DCA
and UDCA followed the procedures presented by the EMEA (Euro-
peanMedicinesAgency–CPMP/ICH/381/95) andANVISA (Brazilian
National Health Surveillance Agency – RE 899, May 2003).
Absorbances vs. concentration linearity was evaluated using
authentic solutions of each bile acid and from them 10 samples at
the range 8.3×10−6 up to 3.36×10−3 mol L−1 forDCAor 8.0×10−6
up to4.0×10−4 mol L−1 forUDCAweremeasured. Assayswith each
solution were performed in triplicate. At the experimental condi-
tions previously established, the linearity of the calibration graphs
were validated for both bile acids by the least squares method and
the one-way analysis of variance (ANOVA) for p<0.05.
Standard curves were then established to ±20% over the spec-
iﬁed range, 5.6×10−4 up to 8.4×10−4 mol L−1 for the DCA and
from 1.52×10−4 up to 2.28×10−4 mol L−1 for the UDCA, respec-
tively. Therefore, results of the triplicate assays at ﬁve different
concentrations were considered.
For evaluation of the repeatability, three concentrations of
the DCA (5.6×10−4, 7.0×10−4 and 8.4×10−4 mol L−1) and UDCA
(1.52×10−4, 1.9×10−4 and 2.28×10−4 mol L−1) were assayed in
nine determinations (3 concentrations/3 replicates).Intermediate
precision was assessed with solutions of the same concentration in
a 22 full factorial design considering different analysts and equip-
ments (PharmaciaUltrospec3000pro andMicronal B582). The limit
of detection was deﬁned as CL =3.3SB/m, where CL, SB, and m are
respectively the limit of detection, standard deviation and slope,
also the same approach was applied for the limit of quantiﬁcation
deﬁned by CLQ =10SB/m.
Accuracy was established by comparison of the concentrations
found in pharmaceutical formulations: Injectable Phosphatidyl-
choline formula (Rotunda et al., 2004) – phosphatidylcholine 5%
(w/v), deoxycholic acid (sodium salt) 4.75% (w/v), benzyl alcohol
0.9% (v/v), water 100mL; injectable deoxycholate formula (Yagima
Odo et al., 2007) – deoxycholic acid (sodium salt) 2.5% (w/v), ben-
zyl alcohol 1% (v/v), propylene glycol 10% (v/v), water 100mL;
Ursacol® – Ursodeoxycholic acid 300mg and excipients (lac-
tose, povidone, crospovidone, magnesium stearate) with the ones
obtained for standardized solutions of DCA (5.6×10−4, 7.0×10−4
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2007; Benesi and Hildebrand, 1949) according to Eqs. (1) and (2):
PHP + -CD -CD–PHP, Kc = [-CD–PHP]
[PHP][-CD]
(1)ig. 1. Absorption spectrum of phenolphthalein (PHP – 1A) (1.55×10−4 mo
p to 6.20×10−4 mol L−1). Determination of (4.38×10−5 up to 7.0×10−4 m
6.2×10−4:1.55×10−4 mol L−1) and (1.19×10−5 up to 1.9×10−4 mol L−1) of urso
3.1×10−4:7.75×10−5 mol L−1).
nd 8.4×10−4 mol L−1) and UDCA (1.52×10−4, 1.9×10−4 and
.28×10−4 mol L−1) in nine determinations (3 concentrations/3
eplicates).
The robustness was evaluated based on the variations in the
nalytical conditions, such as pH (10.3–10.7) and water (distilled,
eionised, double deionised), using different settling conditions for
ach variation.
.3. Optical chemical sensor for bile acids
Optical chemical sensor strips were implemented using
cm×3.5 cm Bristol-paper strips afterwards soaked for 2min in
mL of 1% (w/v) sodium alginate gel containing the -CD–PHP
nclusion complex (6.2×10−4:1.55×10−4 mol L−1 for DCA and
.1×10−4:7.75×10−5 mol L−1 for UDCA) and ﬁnally dried for 24h
25 ◦C). Later, 20L of DCA (1.68×10−3 up to 8.40×10−3 mol L−1)
r UDCA (4.56×10−4 up to 2.28×10−3 mol L−1) solution was
dded. Colour changes were evaluated using a scanner (Model HP
590) for obtaining images with 600dpi deﬁnition. All the images
eredownloaded toa computer, each imagewas converted to8-bit
rayscale by Adobe Photoshop software and the arithmetic mean
f pixel intensity within each test zone was used to quantify the
olorimetric response by the observed RGB (red, green, and blue
olour system) values of digital images (Yang et al., 2007). Finally,
he background-corrected response was calculated by subtraction
f theeach sample andcontrol (withoutbile acids) values (Martinez
t al., 2008a).
. Results and discussion
.1. Development of the method (kit reagent)
The spectral changes obtained for phenolphthalein solutions in
he presence of different-CD concentrations are shown in Fig. 1A.
henolphthalein interacted with the -CD in alkaline pH causing a
ecreaseofmore than95% in theabsorptionbandat thewavelength
f 553nm. The ionised red formof PHPwas forced into-CD cavity,
orming its colourless lactone structure without protonation of the
henolic groups (Afkhami et al., 2006). Spectra of phenolphthalein
olutions with increasing amount of -CD revealed a proportional
ecrease of the free PHP up to concentration of 6.2×10−4 mol L−1
t pH 10.5 resulting in the ratio of 1:4 for PHP:-CD. Higher con-
entrations of -CD did not cause additional observable decrease
n absorbance. However, the addition of bile acids forced the PHP
eaves the cavity of -CD molecules returning to its ionised red
orm in the alkaline solution (Fig. 1B and C). Thus, the extent of theat pH 10.5 in different -cyclodextrin (-CD) concentrations (3.88×10−5
1) deoxycholic acid (DCA – 1B) by the inclusion complex of -CD–PHP
cholic acid concentrations (UDCA – 1C) by the inclusion complex of -CD–PHP
solution colour change can then be easily determined by standard
curve of the free PHP and the corresponding concentration related
with the amount of bile acid.
The effect of temperature on the absorbance of solutions con-
taining the complexes with PHP, DCA and UDCA is presented in
Fig. 2, where can be observed that with the increase of tempera-
ture an increase in absorbance was induced. Similar ﬁndings were
previously described by Zarzycki and Lamparczyk (1998) being this
effect caused by destabilization of the complex (Del Valle, 2004),
with consequent phenolphthalein release. Hence, it becomes dif-
ﬁcult to distinguish between the absorbance increase caused by
an increase in the bile acid afﬁnity by the -CD cavity or the sim-
ple destabilization of the inclusion complex. For this reason, the
temperature for the following studies was ﬁxed at 25 ◦C, once it
was enabled in both extended absorbance range for free PHP and
-CD–PHP inclusion complex, and there was no signiﬁcant differ-
ences for robustness (p<0.05 by Turkey’s test) working between
20 and 30 ◦C.
The equilibrium constants (Kc1:1 bile acid/cyclodextrin) for the
-CD–PHP, -CD–DCA and -CD–UDCA inclusion complexes were
obtained by means of the Benesi–Hildbrand plot (Abdel-Shaﬁ,Fig. 2. Temperature effect (10–55 ◦C) on the phenolphthalein (PHP); -CD–PHP
inclusion complex (6.2×10−4:1.55×10−4 mol L−1) formation and complex interac-
tion with deoxycholic (DCA – 7.0×10−4 mol L−1) and ursodeoxycholic acids (UDCA
– 1.9×10−4 mol L−1).
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Table 1
Equilibrium constants (Kc) of the inclusion complexes: -cyclodextrin–phenolphthalein (-CD–PHP) without or with the deoxycholic acid (DCA) or ursodeoxycholic acid
(UDCA) at different temperatures and the thermodynamic parameters.
Inclusion complexes T Kc G H S
(K) (×104 Lmol−1) (kJmol−1) (kJmol−1) (Jmol−1 K−1)
-CD–PHP 298 1.7(±0.1) −2.4(±0.2) −16(±1) 26(±3)
308 1.4(±0.1) −2.5(±0.2) – –
318 1.17(±0.07) −2.5(±0.2) – –
328 0.93(±0.04) −2.5(±0.1) – –
-CD–DCA 298 2.60(±0.01) −2.53(±0.01) −10(±1) 50(±5)
308 2.39(±0.01) −2.59(±0.01) – –
318 2.12(±0.01) −2.64(±0.01) – –
328 1.77(±0.01) −2.68(±0.01) – –
(±0.0
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l-CD–UDCA 298 2.81
308 2.43
318 2.13
328 1.76
1
A − A0
= 1
a
+ 1
aKc[-CD0]
(2)
here A and A0 are the absorbances of PHP in the presence and
bsence of -CD, respectively, a is a constant related to the molar
bsorption coefﬁcient changes, and [-CD0] is the initial concen-
ration of -CD. Yuexian et al. (2005) described the competitive
omplexationequilibriumconstant (Kc1:1) betweenaminoacid and
ethyl orange that can be applied for Kc determination between
CA or UDCA with -CD by Eqs. (3)–(6):
CA + -CD -CD–DCA, Kc-DCA =
[-CD–DCA]
[DCA][-CD]
(3)
DCA + -CD -CD–UDCA, Kc-UDCA =
[-CD–UDCA]
[UDCA][-CD]
(4)
cBA =
[-CD0] − [CD]
[CD]([BA]0 − [-CD0] + [CD])
(5)
here [BA]0 represented the initial concentration bile acid. KcBA
epresented the equilibrium constant of bile acid–-CD, [CD] was
he uncomplexing -CD concentration when bile acid, PHP and -
Dcoexisted in solutionand itwas related to theabsorbancevariety
f phenolphthalein in solution. [CD] could be obtained from:
CD] = EPHP − E
Kc(E − E-CD–PHP)
(6)
here EPHP and E-CD–PHP represented the absorbance of uncom-
lexing phenolphthalein and -CD–PHP inclusion complex,
espectively;Ewas theabsorbanceof system inwhichbile acid, PHP
nd -CD coexisted (Yuexian et al., 2005). For the selected wave-
ength of 553nm the corresponding molar absorptivity -CD–PHP
omplex is negligible, the absorbance of the solution is mainly
ue to free PHP (uncomplexed). In turn, PHP releasing causes an
bsorbance increase which is proportional to bile acids concentra-
ion in solution, allowing theKcdetermination (Cadenaet al., 2009).
he values of Kc were determined at various temperatures (25 up
o 55 ◦C) and at pH 10.5. Table 1 shows the temperature effect in
he equilibrium constant (Kc1:1 bile acid/cyclodextrin).
The thermodynamic parameters (Table 1) were calculated
ccording to the Van’t Hoff Eq. (7)which describes the temperature
ependence as function of K (Kc1:1). The lnK values were plotted as
function of the inverse temperature to give a linear relationship.
hen, the apparent enthalpy (H) and entropy (S) changes were
btained from the slope and the intercept of the curve (Del Valle,
004; Wang et al., 2007; Yuexian et al., 2005).
nK = −H
RT
+ S
R
(7)1) −2.55(±0.01) −13(±1) 43(±3)
1) −2.59(±0.01) – –
1) −2.64(±0.01) – –
1) −2.67(±0.01) – –
Apparent free energy change (G) was obtained according to
the Eq. (8):
G = −RT lnK (8)
TheVan’tHoff plotswere linear andexhibited largenegativeH
and positive S for the developed complexes; these results were
similar to those reported by Holm et al. (2009) for conjugated bile
acids, suggesting an exothermic inclusion processes.
It was also observed an enthalpy decrease and entropy increase
to the inclusion complexwith thebile acids compared to-CD–PHP
inclusion complex. These results suggested that the inclusion pro-
cesses of DCA andUDCA into the-CD cavityweremore favourable
and spontaneous than that of PHP. In all cases G was negative
showing that the inclusion complexes formation can be sponta-
neous.
According to Jullian et al. (2008), the formation of an inclusion
complex with cyclodextrin occurs due to the hydrogen bonding
with the OH groups at the periphery of the cavity, Van der Waals
and hydrophobic interactions. Generally, solute inclusion in the
cyclodextrin cavity is associated with large negative values of H.
Either negative or slightly positive S values indicating inclu-
sion complexation of the guest without extensive desolvation in
a primarily enthalpy-driven process. The same behaviour has been
reportedby several authorswhichconﬁrmed thegreat contribution
from Van der Walls forces for the complexes formation (Brewster
and Loftsson, 2007; Castronuovo and Niccoli, 2006).
The effect of ionic strength on inclusion of the -CD–PHP com-
plex at constant concentration was examined in the range from
0.11up to0.40. For this study, different concentrations ofNaCl solu-
tion were prepared leading to systems containing H+, Na+, CO3−2,
Cl−, PHP, and -CD. Due to the lower concentration of PHP and the
neutral molecule -CD, their contributions to ionic strength were
negligible, so the H+, Na+, CO3−2 and Cl− are only responsible to
ionic strength in the systems. The changes in the absorbance of
inclusion complex as a function of ionic strength were carried out.
The absorbance of inclusion complex gradually decreased with a
rise in the ionic strength with signiﬁcant difference by the Tukey
test (p<0.05). May be due to the system polarities were enhanced
by ionic strength. Second Wang et al. (2007), the enhancement of
polarity of solution is favourable to the hydrophobic interaction
of -CD molecules, which shields the interaction between -CD
molecule andPHPmolecule and leads todecrease of the absorbance
inclusion complex.
The study of the -CD–PHP inclusion complex as kit reagent
showed that itwas stable for bile acids determinationup to 12days.
A lossof about30% forDCAand12%regardingUDCAdeterminations
were observed after 30 days of storage at 25 ◦C. The inactivation
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Table 2
Validation data (p<0.05).
Linearity
DCA UDCA
Linearity range Standard curve 8.30×10−6–1.68×10−3 mol L−1
ABS=−0.0069(±0.0091) +870.0373(±12.4216)DCAmol/L
8.00×10−6–2.28×10−3 mol L−1
ABS0.5 = 0.0699(±0.011) +4506.688(±77.1179)UDCAmol/L
Correlation coefﬁcient 0.99919 0.99898
Robustnessa
pH DCA UDCA Water DCA UDCA
10.3 – 97.75(±1.49) Distilled 102.38(±1.52) 100.42(±0.95)
10.4 97.84(±3.53) 99.19(±1.76) Deionised 100.11(±4.48) 98.04(±1.86)
10.5 100.00(±3.48) 100.0(±2.15) Double deionised 100(±2.18) 100(±0.66)
10.6 102.62(±2.48) 99.01(±1.85)
10.7 104.50(±0.46) 98.46(±0.97)
a %Mean±%R.S.D.
Table 3
Accuracy of the kit reagent (-CD–PHP) developed for different pharmaceutical formulations.
Drugs Accuracy (%mean±%R.S.D.)
Deoxycholic acid standard 98.97 (±0.84) 101.36(±0.36) 99.31(±1.48)
Injectable Phosphatidylcholine formula (Rotunda et al., 2004) 97.11(±1.43) 101.33(±1.28) 100.51(±0.99)
Injectable deoxycholate formula (Yagima Odo et al., 2007) 98.08(±0.43) 102.77(±0.63) 102.52(±0.38)
99.43
98.1(±
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3Ursodeoxycholic acid standard
Ursacol®
onstant (ki) of the kit reagent was obtained by:
nA = lnA0 − kit (9)
here A0 is the initial absorbance of the bile acids and A is the ﬁnal
bsorbance of the bile acids after 60 days. Furthermore, the half-life
t1/2) can be obtained by:
1/2 =
ln 2
ki
(10)
The inactivation constants (ki) of the kit reagent were of
.01×10−2 day−1 for DCA and 2.35×10−3 day−1 for UDCA deter-
inations. The half-life (t1/2) for the kit reagent was 68.71 days
or DCA and 294.71 days for the UDCA measurements. Despite
he greater stability of the kit reagent for UDCA compared to that
ne for DCA, the last one allowed determinations in more concen-
rated solutions (data not shown) andpharmaceutical formulations
ontaininghighDCAconcentrations (Rotunda et al., 2004; Schuller-
etrovic et al., 2008; Yagima Odo et al., 2007).
ig. 3. Standard curve of the optical chemical sensor for deoxycholic and urso
.1×10−4:7.75×10−5 mol L−1 for UDCA) determinations.(±1.17) 100.89(±0.54) 99.63(±0.21)
0.49) 98.7(±1.86) 99.22(±0.81)
3.2. Validation of the method (kit reagent)
The spectrophotometric method using the developed kit
reagent forDCAandUDCAwasvalidatedaccording to theEMEAand
ANVISA guidelines. Thus the validation characteristics addressed
were linearity, accuracy, precision, speciﬁcity, limits of detection
andquantiﬁcationand robustness (Table2). The standardcurves for
the linearity assays were constructed with 10 concentrations and
validated by the least squares method showing correlation coef-
ﬁcients higher than 0.998 and the one-way analysis of variance
(ANOVA) showing F and p values of 4905.94 and less than 10−10
for DCA and 3415.11 and less than 10−9 for UDCA, respectively. For
the range (80–120%), the standard curves were constructed with 5
concentrations showing correlation coefﬁcients of the same order
of magnitude.
The precision (repeatability) was determined by the per-
centage of relative standard deviation (%R.S.D.) at three levels
(DCA – 5.6×10−4, 7.0×10−4 and 8.4×10−4 mol L−1 and UDCA –
1.52×10−4, 1.9×10−4 and 2.28×10−4 mol L−1). The %R.S.D. values
were less than 3% obtained in the concentrations studied indicating
a good repeatability. The use of an experimental design is encour-
aged by EMEA guidelines, in this way the intermediate precision
deoxycholic acids (-CD–PHP – 6.2×10−4:1.55×10−4 mol L−1 for DCA and
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as studied by a 22 full factorial design which did not present
igniﬁcant effects and interactions (p<0.05). According to these
esults, thedifferent analysts andequipments andyour interactions
id not interfere in the method.
The accuracy results demonstrated themethod effectiveness for
uantitativedeterminationofDCAandUDCA in thepharmaceutical
ormulation. Accuracy was showed as percentage recovery of the
arget value, exhibited excellent results with bias lower than 2%
hroughout the tested range (Table 3). In the concentrations stud-
ed, the excipients used in the formulations and water type did not
nterfere in the results. The optimum pH was ﬁxed at 10.5, condi-
ion that was also reported by Afkhami et al. (2006) and Glazyrin
t al. (2004). Determinations performed at high pH conditions did
ot cause signiﬁcant changes of the results and were limited by the
uffering power of carbonate buffer (Table 2).
The limits of detection were of 4.92×10−5 mol L−1 for DCA
nd 1.14×10−5mol L−1 for UDCA, respectively. The correspond-
ng limits of quantiﬁcation were of 1.64×10−4 mol L−1 and
.79×10−5 mol L−1.
.3. Optical chemical sensor for bile acids
The results obtained concerning robustness of-CD–PHP inclu-
ion complex suggested its biotechnological application in the
orm of optical strip sensor for both qualitative and quantitative
easurements of bile acids. Therefore, a mixture of alginate and-
D–PHP inclusion complex was used to impregnate strips of paper.
lginate is largely used in biomolecule immobilization because it
rovides simple implementation using a biodegradable and non
oxic material (Ha et al., 2009). Furthermore, it did not interfere
ither with the competitive complexation reaction or with the dig-
tal images obtained after colour change induced by the reaction.
he quantitative analysis of digital images obtained from a scan-
er of the optical sensor is a recent tool to measure the amount of
nalytes. This new technology has been showed low cost and sim-
licity, very important for the developing world (Martinez et al.,
008b). The scanners are inexpensive, have high resolution, the
canned image is always in focus, the intensity of the image is
ot affected by lighting conditions, are portables (business card
canners or pen scanners), and they can be linked to personal dig-
tal assistants (PDAs) by wireless communication (Martinez et al.,
008a). In this technique, the analytical signal corresponds to the
GB-based value thatwas calculated fromeach digital image, using
he proposed procedure based on the red, green, and blue colour
ystem (Martinez et al., 2008a; Gaiao et al., 2006; Yang et al., 2007).
The test was only based on dropwise 20L of each bile acid
olution and controls (buffer) in different places on the same strip,
fter 5min at room temperature (25 ◦C)when the tipwas dried, fol-
owed by immediate scanning. However, after the scanning, the tip
olour was observed for 3h without any changes. Based on col-
ected images, it was possible to plot a standard curves (Fig. 3)
or DCA obtaining the equation: RGB=1553 (±32) DCAmol/L −0.8
±0.2) with a correlation coefﬁcient of 0.9994 and UDCA with the
orresponding equation RGB=5671 (±229) UDCAmol/L +0.6 (±0.3)
howing the correlation coefﬁcient of 0.998.
. Conclusion
The development of low cost and simple method for determin-
ngDCA andUDCA are important in quality control of rawmaterials
nd pharmaceutical formulations to prevent misuses and acci-
ents when used for aesthetic purposes, speciﬁcally for the DCA.
he -CD–PHP inclusion complex showed to be a good alternative
ethod for bile acids measurement. The physical–chemical and
hermodynamic parameters studies for the application of inclu-ics of Lipids 164 (2011) 99–105
sion complexes as kit reagent or optical sensor was carried out.
The proposed method had good storage stability, linearity and pre-
cision and can be applied to the analysis of a wide concentration
range of DCA and UDCA in real samples with satisfactory results as
kit reagent. The original optical chemical sensor developed showed
good linearity suggesting that can beused for fast screening and the
analyses “in loco” of bile acids in pharmaceutical formulations or
raw materials.
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